The Latest Breaking News from Obesity

People most used the traffic light system when choosing snacks

Which? called on the Government to make the change amid what it described as an ‘obesity crisis’.

The vast majority of people taking Wegovy and Mounjaro pay privately owing to restrictions on who can access the medicines via the NHS.

For millions of people, weight-loss injections such as Wegovy and Mounjaro have felt like a breakthrough that finally makes eating less feel easier. In a few short years, these so-called GLP-1 drugs have reshaped how obesity is treated and how people think about appetite and willpower. But their success raises…

A loophole in the ban means companies can still advertise brand names, which experts argue leaves children no better protected

In today’s newsletter: As new rules ban TV and online ads for high-fat, salt and sugar products​, the curbing of junk food marketing has found cross-party support

Editorial: Weight-loss drugs cannot solve the problem of poor diet. Ministers are right to demand healthier food and promotions

Waist-to-height ratio ‘outperforms’ BMI in identification of serious health risks, analysis of over 120,000 people suggests

Watchdog will also monitor online ban for high fat and sugar products as part of wider effort to tackle childhood obesity